Experience in using actovegin for focal scleroderma

QR Code

Experience in using actovegin for focal scleroderma

Saved in:

Bibliographic Details
Main Authors:	Mayya Nikolaevna Starovoytova, O V Desinova, Maya Nikolayevna Starovoitova, O. V. Desinova
Format:	Article
Language:	Russian
Published:	IMA-PRESS LLC 2011-09-01
Series:	Современная ревматология
Online Access:	https://mrj.ima-press.net/mrj/article/view/369
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Scleroderma systematica concurrent with neoplasm
by: Maya Nikolayevna Starovoitova, et al.
Published: (2011-06-01)

Use of the international systemic scleroderma activity index
by: Maya Nikolayevna Starovoitova, et al.
Published: (2013-03-01)

Therapy for digital ulcers in patients with systemic scleroderma
by: M. N. Starovoitova, et al.
Published: (2019-01-01)

Skin lesion in scleroderma systematica
by: Maya Nikolayevna Starovoitova
Published: (2010-04-01)

Fibrosing arthropathy in juvenile scleroderma
by: D. A. Dibrov, et al.
Published: (2021-04-01)

COMPLEX THERAPY FOR VASCULAR DISORDERS IN PATIENTS WITH SCLERODERMA SYSTEMATICA
by: M N Starovoitova, et al.
Published: (2009-06-01)

The problem of activity in systemic scleroderma
by: N G Guseva, et al.
Published: (2013-06-01)

ULTRASOUND SCANNING: POSSIBILITIES AND PROSPECTS OF EVALUATING LUNG INVOLVEMENT IN SYSTEMIC SCLERODERMA
by: Olga Borisovna Ovsyannikova, et al.
Published: (2012-12-01)

The use of the Scleroderma Clinical Trials Consortium Damage Index in systemic sclerosis
by: L. P. Ananyeva, et al.
Published: (2025-03-01)

CLINICAL EVALUATION OF THE MANIFESTATIONS OF INTERSTITIAL LUNG INJURYIN SYSTEMIC SCLERODERMA FROM HIGH-RESOLUTION COMPUTER T OMOGRAPHY DATA
by: L P Anan'eva, et al.
Published: (2011-04-01)

Immunological features in anti-U1-ribonucleoprotein antibody positive patients with systemic scleroderma
by: R. U. Shayakhmetova, et al.
Published: (2020-03-01)

SCLERODERMA SYSTEMATICA WITH INTERSTITIAL LUNG LESION: COMPARATIVE CLINICAL CHARACTERISTICSWITH PATIENTS WITHOUT LUNG LESION
by: Lyudmila Valeryevna Teplova, et al.
Published: (2010-06-01)

RITUXIMAB TREATMENT FOR INTERSTITIAL LUNG INJURY IN SCLERODERMA SYSTEMATICA
by: Lidia Petrovna Ananieva, et al.
Published: (2013-12-01)

STUDY OF THE EFFICIENCY AND SAFETY OF MYCOPHENOLATE MOFETIL THERAPY IN PATIENTSWITH SYSTEMIC SCLERODERMA
by: O A Koneva, et al.
Published: (2011-08-01)

Experience of actovegin use in a patient with cognitive impairment in diabetes mellitus (clinical case)
by: M. V. Ovsyuk
Published: (2020-06-01)

Actovegin administration in patients with ulcerated gout tophuses
by: M S Eliseev, et al.
Published: (2005-10-01)

ACTOVEGIN IN THE COMPLEX THERAPY OF VASCULAR DISORDERS IN ANTIPHOSPHOLIPID SYNDROME
by: N V Seredavkina, et al.
Published: (2010-06-01)

A case of osteopoikilia in a female patient with scleroderma systematica
by: Ekaterina Nikolayevna Sukhikh, et al.
Published: (2013-06-01)

Efficacy of Actovegin in the treatment of the central and the peripheral nervous system
by: L. M. Boriskina
Published: (2015-06-01)

Extracutaneous Lesions in Patients with Focal Scleroderma of Craniofacial Localization: a Retrospective Cross-Sectional Study
by: Nikolay N. Murashkin, et al.
Published: (2024-11-01)

Actovegin in the treatment of patients with cognitive impairments in the chronic cerebral ischemia
by: L. M. Boriskina
Published: (2015-12-01)

Scleromyxedema concurrent with dermatomyositis and paraproteinemia: A case report
by: M. N. Starovoitova, et al.
Published: (2015-03-01)

ACTOVEGIN INFLUENCE ON METABOLIC AND VASOMOTOR FUNCTION OF MICROVASCULAR ENDOTHELIAL OF HUMAN SKIN
by: A. A. Fedorovich, et al.
Published: (2016-01-01)

EXPERIENCE OF RITUXIMAB TREATMENT IN A PATIENT WITH JUVENILE SCLERODERMA
by: E. I. Alexeeva, et al.
Published: (2012-05-01)

Scleroderma-panniculitis: view of the rheumatologist
by: A. S. Potapova, et al.
Published: (2021-04-01)

SUBTYPES OF JUVENILE SYSTEMIC SCLERODERMA
by: M N Slarovoitova, et al.
Published: (2001-04-01)

Pregnancy and Scleroderma
by: Gorgiard, Charlotte, et al.
Published: (2012)

Experience with Lipofilling in Children with Localized Scleroderma: Case Study
by: Alina R. Misbakhova, et al.
Published: (2024-11-01)

Treatment for systemic scleroderma
by: Rezvaya Tairovich Alekperov, et al.
Published: (2011-09-01)

Scleroderma and Breast Cancer
by: Michalinos, Adamantios, et al.
Published: (2011)

Scleroderma Renal Crisis
by: Chabtini, Lola, et al.
Published: (2012)

DIAGNOSTIC VALUE OF CERULOPLASMIN IN SYSTEMIC SCLERODERMA
by: O. I. Emelyanova, et al.
Published: (2019-05-01)

Prospects for using mycophenolate mofetil in diffuse scleroderma
by: L P Ananyeva
Published: (2009-03-01)

Experience of using EpiTapp application in structural focal epilepsy
by: E. A. Narodova, et al.
Published: (2022-01-01)

DIFFERENTIAL DIAGNOSIS IN JUVENILE SCLERODERMA
by: M.K. Osminina, et al.
Published: (2008-01-01)

Differential diagnosis of myopathic syndrome in dermatomyositis/polymyositis and progressive muscular dystrophies (description of a case)
by: Olga Alekseevna Antelava, et al.
Published: (2012-12-01)

Bone mineral density in patients with systemic scleroderma
by: O. V. Dobrovolskaya, et al.
Published: (2019-03-01)

Comparative investigation of dimephosphon, actovegin and trental influence on survival potention of skin-fascial autograft in arterial blood insufficiency and venous stasis
by: D. A. Nefedov, et al.
Published: (2016-06-01)

Frequency of occurrenceof tumor-associated localized scleroderma
by: P. O. Kazakova
Published: (2025-05-01)

DIAGNOSIS OF PULMONARY HYPERTENSION IN SCLERODERMA SYSTEMATICA
by: A V Volkov, et al.
Published: (2008-12-01)